McCormick EE, Francis BJ, Gelb AG. A new antibody apparently defining an allele of Goa (abstract). Transfusion 1965; 5:369–70.Search in Google Scholar
Stroup M, McCreary J. Cra another high-frequency blood group factor (abstract). Transfusion 1975;15:522.Search in Google Scholar
Daniels G. Characterization of Cromer-related antibodies (abstract). Transfusion 1983;23:410.Search in Google Scholar
Spring FA, Judson PA, Daniels GL, Parsons SF, Mallinson G, Anstee DJ. Human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987; 62:307–13.Search in Google Scholar
Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988; 167:1993–8.10.1084/jem.167.6.1993Search in Google Scholar
Holmes CH, Simpson KL. Complement and pregnancy: new insights into the immunobiology of the foeto-maternal relationships. Baillèrés Clin Obstet Gynaecol 1992;Vol.6(No.3): 439–60.10.1016/S0950-3552(05)80005-7Search in Google Scholar
Shibuya K, Abe T, Fujita T. Decay-accelerating factor functions as a signal transducing molecule for human monocytes. J Immunol 1992; 149:1758–62.10.4049/jimmunol.149.5.1758Search in Google Scholar
Finberg RW, White W, Nicholson-Weller A. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells. J Immunol 1992; 149: 2055–60.10.4049/jimmunol.149.6.2055Search in Google Scholar
Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory protein decay-accelerating factor at the foeto-maternal interface during human pregnancy. J Immunol 1990; 1.44:3099–105.10.4049/jimmunol.144.8.3099Search in Google Scholar
Daniels GL, Tohyama IT, Uchikawa M. A possible null phenotype in the Cromer blood group complex. Transfusion 1982;22:362–3.10.1046/j.1537-2995.1982.22583017458.x7123631Search in Google Scholar
Tate CG, Uchikawa M, Tanner MJA, et al. Studies on the defect which causes absence of decay-accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype. BiochemJ 1989;261:489–93.10.1042/bj261048911388522476116Search in Google Scholar
Marsh WL. Scoring of hemagglutinating reactions. Transfusion 1972;12:352–3.10.1111/j.1537-2995.1972.tb04459.x5072588Search in Google Scholar
Hadley AG, Kumpel BM, Leader K, Merry AH, Brojer E, Zupanska B. An in vitro assessment of the functional activity of monoclonal anti-D antibodies. Clin Lab Hematol 1989;11:47–54.10.1111/j.1365-2257.1989.tb00173.x2495881Search in Google Scholar
Kumpel BM, Leader KA, Merry AH, et al. Heterogeneity in the ability of IgGl monoclonal anti-D to promote lymphocyte-mediated red cell lysis. Eur J Immunol 1989;19:2283–8.10.1002/eji.18301912162481589Search in Google Scholar
